Question 1

What does Saphira Labs do?

Accepted Answer

Saphira Labs is developing a human cardiac organoid platform that combines stem-cell-derived heart tissue with high-resolution genomic analysis to identify early cardiac injury signals and biomarker patterns associated with drug-induced cardiotoxicity.

Question 2

Who is Saphira Labs built for?

Accepted Answer

Safety and toxicology teams at the last checkpoint before a candidate clears into trial, and high-throughput, AI-enabled drug discovery teams that need the human biology data their models are missing.

Question 3

What makes the Saphira approach different?

Accepted Answer

The inputs. Saphira selects and filters the data its models are built on to strip out confounding signal, so what remains is attributable to the compound rather than to the population it was measured in. That curated input, run through the company's experimental techniques and analytical suites, is what the platform is built on.

Question 4

What is Saphira OmniCore?

Accepted Answer

Saphira OmniCore is the company's cardiac safety platform. It combines human-relevant 3D cardiac tissue with high-resolution genomics to produce cardiac toxicity monitoring and licensable cardiac safety datasets.

Cardiac risk, answered before the clinic.